Laurie J. Olson, Director at Karuna Therapeutics, Inc. (KRTX), sold 1,000 shares at $181.02 ($181K) on 2023-04-03, disclosed to the SEC on 2023-04-05.
Scheduled sale ($181k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| QTRX | SELL | 2024-02-15 | $37K | — | Filing → |
| QTRX | SELL | 2024-01-04 | $27K | — | Filing → |
| QTRX | SELL | 2023-11-14 | $33K | — | Filing → |